To Get More Information on Image-guided Biopsy Market - Request Sample Report
The Image-guided Biopsy Market size was valued at USD 2390.85 million in 2023 and is expected to grow to USD 3669.20 million by 2031 and grow at a CAGR of 5.50% over the forecast period of 2024-2031.
Image-guided biopsy is a crucial medical technology that is utilized in the identification of abnormal cell and tissue growth to determine the presence of underlying malignant behavior. The extent and variety of activities, goods, and services associated with image-guided biopsy methods and technologies are referred to as the image-guided biopsy market's scope. Image-guided biopsy is a minimally invasive process that directs the placement of a biopsy needle or other instrument into a predetermined target location for tissue sampling using imaging techniques including ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), or fluoroscopy.
There are several different types of image-guided biopsy techniques available on the market, including fluoroscopy-, MRI-, CT-, and ultrasound-guided treatments. There are specific imaging modalities and procedures for each product of the treatment. Image-guided biopsies can be carried out for a variety of medical purposes, such as cancer diagnosis and staging, evaluation, and monitoring.
The global market for medical treatments that employ imaging technologies to direct and aid in the biopsy process is referred to as the "Image-Guided Biopsy Market." A biopsy is a medical operation in which a sample of tissue or cells is extracted for diagnostic reasons from a particular location of the body. Image-guided biopsies precisely find and target the target area for the biopsy using imaging modalities including ultrasound, magnetic resonance imaging (MRI), computed tomography (CT), or X-ray.
KEY DRIVERS:
Advancements in imaging technologies
Minimally invasive procedures
The increasing prevalence of Cancer incidence is rising worldwide, which is one of the main factors driving the market for image-guided biopsies. Breast, lung, prostate, liver, and kidney cancers are just a few of the many types of cancer that can be diagnosed with image-guided biopsies. The demand for image-guided biopsy techniques is anticipated to expand as cancer prevalence keeps rising.
RESTRAIN:
Risk of infection from using a biopsy needle
Limited Knowledge and Training
Cost Restrictions
Regulatory Obstacles
Limited Knowledge and Training: Image-guided biopsies involve intricate processes and call for specialized training for medical staff. The broad use of these strategies may be hampered by a lack of awareness and training opportunities, particularly in areas with limited resources.
OPPORTUNITY:
Rising cancer incidence
Image-guided biopsies are becoming more accurate and effective thanks to ongoing advances in imaging technologies including high-resolution ultrasonography, multiparametric MRI, and cone-beam CT. The spectrum of applications is growing, and image-guided biopsy techniques are being used more frequently as a result of these technical advancements.
Image-guided biopsy methods are less intrusive than conventional surgical biopsies, which results in less discomfort for patients, quicker recoveries, and cheaper healthcare expenditures. Image-guided biopsy procedures are expanding due to the demand for least invasive methods.
CHALLENGES:
Cost factors
Education and experience
Accessibility issues of Image-guided biopsy treatments call for specialized tools and qualified medical personnel. The broad use of image-guided biopsy procedures may be hampered in some areas by a lack of access to these tools, especially in rural or underdeveloped nations.
IMPACT OF COVID-19
Image-guided biopsies were among the non-urgent medical treatments that were delayed or abandoned in the early stages of the pandemic to give COVID-19 patients priority. There was a considerable drop in the volume of image-guided biopsies carried out at that time.
Because they were concerned about getting sick from the virus, many people avoided going to hospitals and other healthcare institutions. As a result, fewer patients visited for routine examinations and screenings, such as image-guided biopsies.
The ongoing conflict between Russia and Ukraine has unquestionably had a big impact on a variety of areas of both countries. The market for image-guided biopsies is mostly driven by technology breakthroughs, medical advances, and healthcare infrastructure, thus it is unclear how this would directly affect the industry.
Image-guided biopsies are medical procedures in which a biopsy needle is inserted into a specified region to collect tissue samples for diagnosis using imaging techniques including ultrasound, CT scans, MRIs, or X-rays. The market for image-guided biopsies is impacted by several variables, including the frequency of disorders that call for biopsies, developments in imaging technology, the accessibility of qualified medical personnel, and reimbursement regulations.
IMPACT OF ONGOING RECESSION
There are several potential effects on the healthcare sector as a whole during a recession or downturn that could indirectly affect the market for image-guided biopsiesDuring recessions, healthcare spending tends to be constrained because institutions like hospitals and clinics may experience financial difficulties. Image-guided biopsies may be adopted and used less frequently as a result, which could affect capital equipment and medical procedure spending.
Patient Demand Declines During economic downturns, people may experience financial difficulties, lose their health insurance coverage, or put off non-essential medical operations because of cost considerations. This would cause fewer patients to request image-guided biopsies, which would decrease the demand for these treatments as a whole. Healthcare providers could postpone or delay making capital investments in costly, During recessions, one may postpone or delay making large capital purchases of pricey imaging equipment or updating current systems. This might affect consumer spending on imaging tools for image-guided biopsies, reducing the market's expansion.
North America currently holds a dominant position in the market for biopsy devices. The high demand for biopsy devices in the region is a result of the presence of major industry players in the region, rising per capita healthcare spending, and expanding adoption of new and cutting-edge diagnostic techniques.
Asia-Pacific is predicted to have a considerable increase from 2024 to 2031 because of the region's large senior population, rising cancer rates in nations like Australia, China, and India, as well as the region's improving healthcare infrastructure.
Do You Need any Customization Research on Image-guided Biopsy Market - Enquire Now
The Major Players are Ethicon Endo-Surgery, Intact Medical Corporation, Galini SRL, Hologic Inc., Leica Biosystems Nussloch GmbH, C. R. Bard, Inc., Becton and Dickinson Company, Argon Medical Devices, Cook Medical Incorporated, Encapsule Medical Devices LLC. & Other players are listed in the final report.
Image -Guided biopsy system with CorLumina Imaging Technology get European CE mark approval. This system's goals include enhancing patient happiness, streamlining the biopsy suite process, and increasing biopsy accuracy using real-time imaging.
The Brevera Breast Biopsy System with CorLumina Imaging Technology was introduced by Hologic for commercial use in the US. With real-time imaging, this device aims to increase biopsy accuracy, enhance patient comfort, and speed up the entire biopsy procedure.
| Report Attributes | Details |
| Market Size in 2023 | US$ 2390.85 Mn |
| Market Size by 2031 | US$ 3669.20 Mn |
| CAGR | CAGR of 5.50% From 2024 to 2031 |
| Base Year | 2023 |
| Forecast Period | 2024-2031 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Process (Vacuum, Assisted Biopsy, Core Needle, Fine Needle) • By Technology (MRI Guided, Ultrasound Guided, Mammography, CT, X-Ray) • By End User (Hospitals And Clinics, Ambulatory Surgical Centes, Research and Academic Institutes) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Ethicon Endo-Surgery, Intact Medical Corporation, Galini SRL, Hologic Inc., Leica Biosystems Nussloch GmbH, C. R. Bard, Inc., Becton and Dickinson Company, Argon Medical Devices, Cook Medical Incorporated, Encapsule Medical Devices LLC. |
| Key Drivers | • Advancements in imaging technologies • Minimally invasive procedures |
| Market Opportunities | • Rising cancer incidence |
ANS: The Image-guided Biopsy Market is predicted to grow at a 5.50% CAGR.
ANS: A market size of the Image-guided Biopsy Market is USD 2390.85 million in 2023.
ANS: Risk of infection from using a biopsy needle, Limited Knowledge and Training, Cost Restrictions, and Regulatory Obstacles
ANS:1. Electronic Transformation
2. Machine learning (ML) and artificial intelligence (AI)
3. Internet Of Things (IoT).
ANS: North America currently holds a dominant position in the market for biopsy devices.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of covid-19
4.2 Impact of the Russia-Ukraine War
4.4 Impact of Ongoing Recession
4.4 Introduction
4.4.1 Impact on major economies
4.4.1.1 US
4.4.1.2 Canada
4.4.1.3 Germany
4.4.1.4 France
4.4.1.5 United Kingdom
4.4.1.6 China
4.4.1.7 japan
4.4.1.8 South Korea
4.4.1.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Image-Guided Biopsy Market Segmentation, By Process
8.1 Vacuum-Assisted Biopsy
8.2 Core Needle
8.3 Fine Needle
9. Image-Guided Biopsy Market Segmentation, By Technology
9.1 MRI
9.2 Ultrasound
9.3 Mammography
9.4 CT
9.5 X-Ray
10. Image-Guided Biopsy Market Segmentation, By End-user
10.1 Hospitals And Clinics
10.2 Ambulatory Surgical Centers
10.3 Research and Academic Institutes
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 North America Image-Guided Biopsy Market by Country
11.2.2North America Image-Guided Biopsy Market by Process
11.2.3 North America Image-Guided Biopsy Market by By Technology
11.2.4 North America Image-Guided Biopsy Market by End-user
11.2.5 USA
11.2.5.1 USA Image-Guided Biopsy Market by Process
11.2.5.3 USA Image-Guided Biopsy Market by By Technology
11.2.5.4 USA Image-Guided Biopsy Market by End-user
11.2.6 Canada
11.2.6.1 Canada Image-Guided Biopsy Market By Process
11.2.6.3 Canada Image-Guided Biopsy Market by By Technology
11.2.6.4 Canada Image-Guided Biopsy Market by End-user
11.2.7 Mexico
11.2.7.1 Mexico Image-Guided Biopsy Market By Process
11.2.7.3 Mexico Image-Guided Biopsy Market by By Technology
11.2.7.4 Mexico Image-Guided Biopsy Market by End-user
11.3 Europe
11.3.1 Europe Image-Guided Biopsy Market by Country
1.3.3.2 Europe Image-Guided Biopsy Market By Process
11.3.3 Europe Image-Guided Biopsy Market by By Technology
11.3.4 Europe Image-Guided Biopsy Market by End-user
11.3.5 Germany
11.3.5.1 Germany Image-Guided Biopsy Market By Process
11.3.5.2 Germany Image-Guided Biopsy Market by By Technology
11.3.5.3 Germany Image-Guided Biopsy Market by End-user
11.3.6 UK
11.3.6.1 UK Image-Guided Biopsy Market By Process
11.3.6.2 UK Image-Guided Biopsy Market by By Technology
11.3.6.3 UK Image-Guided Biopsy Market by End-user
11.3.7 France
11.3.7.1 France Image-Guided Biopsy Market By Process
11.3.7.2 France Image-Guided Biopsy Market by By Technology
11.3.7.3 France Image-Guided Biopsy Market by End-user
11.3.8 Italy
11.3.8.1 Italy Image-Guided Biopsy Market By Process
11.3.8.2 Italy Image-Guided Biopsy Market By Technology
11.3.8.3 Italy Image-Guided Biopsy Market by End-user
11.3.9 Spain
11.3.9.1 Spain Image-Guided Biopsy Market By Process
11.3.9.2 Spain Image-Guided Biopsy Market By Technology
11.3.9.3 Spain Image-Guided Biopsy Market by End-user
11.3.10 The Netherlands
11.3.10.1 Netherlands Image-Guided Biopsy Market By Process
11.3.10.2 Netherlands Image-Guided Biopsy Market By Technology
11.3.10.3 Netherlands Image-Guided Biopsy Market by End-user
11.3.11 Rest of Europe
11.3.11.1 Rest of Europe Image-Guided Biopsy Market By Process
11.3.11.2 Rest of Europe Image-Guided Biopsy Market By Technology
11.3.11.3 Rest of Europe Image-Guided Biopsy Market by End-user
11.4 Asia-Pacific
11.4.1 Asia Pacific Image-Guided Biopsy Market by Country
11.4.2 Asia Pacific Image-Guided Biopsy Market by Process
11.4.3 Asia Pacific Image-Guided Biopsy Market By Technology
11.4.4 Asia Pacific Image-Guided Biopsy Market by End-user
11.4.5 Japan
11.4.5.1 Japan Image-Guided Biopsy Market By Process
11.4.5.2 Japan Image-Guided Biopsy Market By Technology
11.4.5.3 Japan Image-Guided Biopsy Market by End-user
11.4.6 South Korea
11.4.6.1 South Korea Image-Guided Biopsy Market By Process
11.4.6.2 South Korea Image-Guided Biopsy Market By Technology
11.4.6.3 South Korea Image-Guided Biopsy Market by End-user
11.4.7 China
11.4.7.1 China Image-Guided Biopsy Market by Process
11.4.7.2 China Image-Guided Biopsy Market By Technology
11.4.7.3 China Image-Guided Biopsy Market by End-user
11.4.8 India
11.4.8.1 India Image-Guided Biopsy Market By Process
11.4.8.2 India Image-Guided Biopsy Market By Technology
11.4.8.3 India Image-Guided Biopsy Market by End-user
11.4.9 Australia
11.4.9.1 Australia Image-Guided Biopsy Market By Process
11.4.9.2 Australia Image-Guided Biopsy Market By Technology
11.4.9.3 Australia Image-Guided Biopsy Market by End-user
11.4.10 Rest of Asia-Pacific
11.4.10.1 APAC Image-Guided Biopsy Market By Process
11.4.10.2 APAC Image-Guided Biopsy Market by By Technology
11.4.10.3 APAC Image-Guided Biopsy Market by End-user
11.5 The Middle East & Africa
11.5.1 The Middle East & Africa Image-Guided Biopsy Market by Country
11.5.2 The Middle East & Africa Image-Guided Biopsy Market by Process
11.5.3 The Middle East & Africa Image-Guided Biopsy Market By Technology
11.5.4 The Middle East & Africa Image-Guided Biopsy Market by End-user
11.5.6 Israel
11.5.6.1 Israel Image-Guided Biopsy Market By Process
11.5.6.2 Israel Image-Guided Biopsy Market By Technology
11.5.6.3 Israel Image-Guided Biopsy Market by End-user
11.5.6 UAE
11.5.6.1 UAE Image-Guided Biopsy Market By Process
11.5.6.2 UAE Image-Guided Biopsy Market By Technology
11.5.6.3 UAE Image-Guided Biopsy Market by End-user
11.5.7 South Africa
11.5.7.1 South Africa Image-Guided Biopsy Market by Process
11.5.7.2 South Africa Image-Guided Biopsy Market By Technology
11.5.7.3 South Africa Image-Guided Biopsy Market by End-user
11.5.8 Rest of Middle East & Africa
11.5.8.1 Rest of Middle East & Asia Image-Guided Biopsy Market by Process
11.5.8.2 Rest of Middle East & Asia Image-Guided Biopsy Market Phase
11.5.8.3 Rest of Middle East & Asia Image-Guided Biopsy Market by End-user
11.6 Latin America
11.6.1 Latin America Image-Guided Biopsy Market by Country
11.6.2 Latin America Image-Guided Biopsy Market by Process
11.6.3 Latin America Image-Guided Biopsy Market By Technology
11.6.4 Latin America Image-Guided Biopsy Market by End-user
11.6.5 Brazil
11.6.5.1 Brazil Image-Guided Biopsy Market By Process
11.6.5.2 Brazil Image-Guided Biopsy Market By Technology
11.6.2.3 Brazil Image-Guided Biopsy Market by End-user
11.6.6 Argentina
11.6.6.1 Argentina Image-Guided Biopsy Market By Process
11.6.6.2 Argentina Image-Guided Biopsy Market By Technology
11.6.6.3 Argentina Image-Guided Biopsy Market by End-user
11.6.7 Rest of Latin America
11.6.7.1 Rest of Latin America Image-Guided Biopsy Market by Process
11.6.7.2 Rest of Latin America Image-Guided Biopsy Market By Technology
11.6.7.3 Rest of Latin America Image-Guided Biopsy Market by End-user
12. Company Profile
12.1 Ethicon Endo-Surgery
12.1.1 Market Overview
12.1.2 Financials
12.1.3 Products/ Services /Offered
12.1.4 SWOT Analysis
12.1.5 The SNS View
12.2 Intact Medical Corporation
12.2.1 Market Overview
12.2.2 Financials
12.2.3 Products/ Services Offered
12.2.4 SWOT Analysis
12.2.5 The SNS View
12.3 Galini SRL
12.3.1 Market Overview
12.3.2 Financials
12.3.3 Product/Services/ Offerings
12.3.4 SWOT Analysis
12.3.5 The SNS View
12.4 Hologic Inc
12.4.1 Market Overview
12.4.2 Financials
12.4.4 Product/Services /Offerings
12.4.4 SWOT Analysis
12.4.5 The SNS View
12.5 Leica Biosystems Nussloch GmbH
12.5.1 Market Overview
12.5.2 Financials
12.5.3 Products/ Services /Offered
12.5.4 SWOT Analysis
12.5.5 The SNS View
12.6 C. R. Bard Inc.
12.6.1 Market Overview
12.6.2 Financials
12.6.3 Products/ Services /Offered
12.6.4 SWOT Analysis
12.6.5 The SNS View
12.7 Becton and Dickinson Company
12.7.1 Market Overview
12.7.2 Financials
12.7.3 Products/ Services/ Offered
12.7.4 SWOT Analysis
12.7.5 The SNS View
12.8 Argon Medical Devices
12.8.1 Market Overview
12.8.2 Financials
12.8.3 Products/ Services /Offered
12.8.4 SWOT Analysis
12.8.5 The SNS View
12.9 Cook Medical Incorporated
12.9.1 Market Overview
12.9.2 Financials
12.9.3 Products/ Services/ Offered
12.9.4 SWOT Analysis
12.9.5 The SNS View
12.10 Encapsule Medical Devices LLC
12.10.1 Market Overview
12.10.2 Financials
12.10.3 Products/ Services /Offered
12.10.4 SWOT Analysis
12.10.5 The SNS View
13. Competitive Landscape
13.1 Competitive Benchmarking
13.2 Market Share Analysis
13.4 Recent Developments
14. USE Cases and Best Practices
15. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
By Process:
Vacuum Assisted Biopsy
Core Needle
Fine Needle
By Image Guided Technology:
MRI
Ultrasound
CT
X-Ray
By End User:
Hospitals And Clinics
Research and Academic Institutes
Request for Segment Customization as per your Business Requirement: Segment Customization Request
REGIONAL COVERAGE:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The High Throughput Screening Market Size was valued at USD 25.80 billion in 2023 and is witnessed to reach USD 69.46 Billion by 2032 and grow at a CAGR of 12.18% over the forecast period 2024-2032.
The Blood Screening Market size was estimated USD 3.02 billion in 2023 and is expected to reach USD 7.37 billion By 2031 at a CAGR of 11.8% during the forecast period of 2024-2031.
The Circulating Tumor Cells Market size was estimated at USD 11.35 billion in 2023 and is expected to reach USD 36.33 billion by 2032 with a growing CAGR of 13.8% during the forecast period of 2024-2032.
The Dual Chamber Prefilled Syringes Market size was USD 154.21 million in 2022 and is expected to Reach USD 268.56 million by 2030 and grow at a CAGR of 7.08 % over the forecast period of 2023-2030.
The Legal Marijuana Market size was valued at USD 21.08 billion in 2023 and is supposed to grow at a CAGR of 25.6% from 2024 to 2031. the legal marijuana market is estimated to reach 130.55 billion by 2031.
The Topical Drug Delivery Market Size was valued at USD 210.03 Billion in 2023 and is expected to reach USD 499.39 Billion by 2032 and grow at a CAGR of 10.62% over the forecast period 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
